New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Vyome Holdings, Inc.

HIND

Healthcare Biotechnology

Vyome Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $319,700.00, up 24.4% from fiscal 2024.

Revenue
+67.6%
EPS
n/m
Free cash flow
n/m

Quarter to September 2026, against a year earlier

1.20 0.25 −17.24%
Market cap
$10.2M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
4/9
ROIC
0.00%
Net debt / EBITDA
0.5×
Payout ratio
—

Revenue to profit Twelve months to Sep 30, 2026

It lost $3.9M on $153.2K of revenue: $2555.61 for every $100. Gross margin has fallen three quarters running, from 68.4% to 50.4%. What is an income statement?

Revenue to profit, in millions of dollars and as a share of revenue
Revenue0.2100.0%
Cost of revenue−0.1−49.6%
Gross profit0.150.4%
Research & development−2.0−1280.2%
Selling, general & admin−2.5−1614.9%
Other operating costs0.0−6.9%
Operating income−4.4−2851.6%
Other income, net+0.5296.0%
Net income−3.9−2555.6%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$0.0B$0.0B$0.0B$0.0B
Operating income−$10M−$11M−$12M−$4.4M
Net income−$10M−$11M−$12M−$3.9M
Net margin (right axis)−3276.3%−7309.7%−8921.6%−2555.6%
Older periods Dec '25 Mar '26 Jun '26 Sep '26
Revenue

+8 more TTM periods

0.32 0.15 0.13 0.15
Gross Profit
0.22 0.08 0.07 0.08
Operating Income
(10.45) (11.38) (11.92) (4.37)
EBT
(10.48) (11.17) (11.58) (3.92)
Income after Tax
(10.48) (11.17) (11.58) (3.92)
Net Income Common
(10.26) (10.93) (11.31) (3.76)
EPS (Diluted)
(1,536.82) (775.38) (3.58) (0.59)
Shares (Diluted, Weighted)
2.16 3.83 5.59 6.65
Gross Margin
68.42% 53.01% 52.77% 50.39%
EBIT Margin
(3,268.48%) (7,449.93%) (9,184.82%) (2,851.63%)
Net Profit Margin
(3,208.91%) (7,153.80%) (8,711.71%) (2,453.92%)
Free Cash Flow Margin
(1,172.26%) (3,260.08%) (4,298.00%) (2,928.92%)
EBITDA
(10.44) (11.37) (11.91) (4.36)
EBIT
(10.45) (11.38) (11.92) (4.37)

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026